Cost-effectiveness of obinutuzumab plus bendamustine followed by obinutuzumab monotherapy for the treatment of follicular lymphoma patients who relapse after or are refractory to a rituximab-containing regimen in the US
| Image |  |
|---|---|
| Description | scientific article published on 06 July 2018 |
| Author/s |
author: Gregory F Guzauskas |
| Publication date | July 6, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |